Ribovate Therapeutics

Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform.

Startup Details

Co-Founded by: Drew Weissman and Hamideh Parhiz

Participates in PCI Ventures UPstart

2023 PCI Ventures at Pennovation Works Showcase Puts Startup Growth and the Entrepreneurial Journey in the Spotlight 

PCI highlights mRNA Innovation at JPM

Penn Startups Raising Money in 2023

PCI Ventures Presents at Pennovation Works Showcase



Skip to content